Sublingual immunotherapy: the quest for innovative adjuvants.
Goldman
M
M
D000276:Adjuvants, Immunologic / Q000008:administration & dosage / Q000627:therapeutic use*; D000286:Administration, Sublingual; D000818:Animals; D016207:Cytokines / Q000378:metabolism; D003713:Dendritic Cells / Q000276:immunology / Q000378:metabolism; D003888:Desensitization, Immunologic / Q000379:methods*; D006801:Humans; D007108:Immune Tolerance / Q000276:immunology; D018928:Immunity, Mucosal / Q000276:immunology; D055666:Lipopeptides / Q000008:administration & dosage / Q000627:therapeutic use; D012130:Respiratory Hypersensitivity / Q000276:immunology / Q000628:therapy; D016176:T-Lymphocyte Subsets / Q000276:immunology / Q000378:metabolism; D051193:Toll-Like Receptors / Q000819:agonists / Q000502:physiology
D000276:Adjuvants, Immunologic; D016207:Cytokines; D055666:Lipopeptides; C508075:Pam(3)CSK(4) peptide; D051193:Toll-Like Receptors